US Stock MarketDetailed Quotes

ORIC Oric Pharmaceuticals

Watchlist
  • 7.670
  • -0.410-5.07%
Close Apr 25 16:00 ET
  • 7.830
  • +0.160+2.09%
Post 16:29 ET
517.13MMarket Cap-3913P/E (TTM)

About Oric Pharmaceuticals Company

Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA.

Company Profile

SymbolORIC
Company NameOric Pharmaceuticals
Listing DateApr 24, 2020
Issue Price16.00
Founded2014
CEOMr. Jacob M. Chacko, M.B.A.,M.D.
MarketNASDAQ
Employees100
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address240 East Grand Avenue,2nd Floor
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-388-5600
Websitehttp://www.oricpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Jacob M. Chacko, M.B.A.,M.D.
  • President, Chief Executive Officer and Director
  • 4.37M
  • Pratik S. Multani, M.D.
  • Chief Medical Officer
  • 1.91M
  • Dominic G. Piscitelli
  • Chief Financial Officer and Principal Accounting Officer
  • 1.92M
  • Richard Heyman, PhD
  • Chairman of the Board
  • 239.87K
  • Steven L. Hoerter
  • Independent Director
  • 185.11K
  • Dr. Angie You
  • Independent Director
  • 170.22K
  • Mardi C. Dier
  • Independent Director
  • 200.87K
  • Dr. Lori Anne Kunkel, M.D.
  • Independent Director
  • 186.87K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg